Organ-on-a-chip systems might become the most advanced miniature multiorganoid model in the near future, serving as a bridge between cell models and the human body. The premise behind this technique is that microfluidic connections allow many organoids of various cells to be grouped together in a body-like way. The integration of sensors into such systems is the key benefit, as it allows for real-time monitoring of physical, biochemical, and optical properties in situ. When the multisensory platform is completed, drug development, pharmacodynamics investigations, and preclinical drug testing, which includes patient-derived personal models, will be able to more correctly anticipate toxicity and treatment outcome.
3D cell culture models have demonstrated a number of clear benefits over 2D cell cultures. Organ on a Chip have a lot of potential in basic research as well as in the pharmaceutical sector. Several studies have found that the identical cells cultivated in 2D or 3D have distinct morphological and physiological properties, resulting in a different biological response. Signal transmission and gene expression are influenced by the capacity of 3D cultures to engage with intercellular and cellular matrix interactions. As a result, cell activity in 3D cultures resembles cellular response in vivo more closely. Physiological relevance, high throughput, and repeatability are all important considerations for developing novel 3D cell culture models.
Source Link- https://cmiblogdailydose.blogspot.com/2022/06/organ-on-chip-is-physiological-organ.html
